002030 達安基因
按盤價 
6.640 +0.600 (+9.934%)
6.640 +0.600 (+9.934%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.385 | -9.913 | -11.040 | 1.037 | 58.034 |
| 總資產報酬率 ROA (%) | -1.165 | -8.231 | -8.984 | 0.812 | 43.137 |
| 投入資產回報率 ROIC (%) | -1.331 | -9.516 | -10.492 | 0.991 | 54.967 | 邊際利潤分析 |
| 銷售毛利率 (%) | 30.767 | 32.401 | 37.547 | 50.467 | 72.842 |
| 營業利潤率 (%) | -66.444 | -99.431 | -125.155 | 10.299 | 52.542 |
| 息稅前利潤/營業總收入 (%) | -68.629 | -104.685 | -133.200 | 3.285 | 51.534 |
| 淨利潤/營業總收入 (%) | -65.710 | -103.017 | -110.092 | 6.074 | 45.056 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 55.804 | 39.268 | 19.142 | 41.799 | 108.478 |
| 價值變動淨收益/利潤總額(%) | 67.243 | -7.134 | 40.104 | 360.629 | 5.594 |
| 營業外收支淨額/利潤總額(%) | 0.553 | 0.480 | 0.332 | -7.122 | -0.163 | 償債能力分析 |
| 流動比率 (X) | 2.980 | 2.823 | 2.923 | 3.085 | 2.954 |
| 速動比率 (X) | 2.824 | 2.676 | 2.770 | 2.946 | 2.829 |
| 資產負債率 (%) | 12.809 | 13.463 | 14.972 | 16.889 | 21.286 |
| 帶息債務/全部投入資本 (%) | 2.261 | 1.942 | 2.488 | 4.150 | 2.072 |
| 股東權益/帶息債務 (%) | 4,245.617 | 4,953.751 | 3,850.355 | 2,273.624 | 4,656.178 |
| 股東權益/負債合計 (%) | 659.420 | 622.998 | 549.549 | 477.214 | 359.775 |
| 利息保障倍數 (X) | 37.801 | 21.927 | 17.462 | -0.519 | -55.909 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 441.046 | 475.119 | 698.914 | 933.398 | 94.518 |
| 存貨周轉天數 (天) | 128.210 | 121.527 | 147.901 | 187.444 | 47.499 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
